Agonist in Rats-Opioid Receptor κ Prolonged Opportunity for Ischemic Neuroprotection with Selective
暂无分享,去创建一个
[1] J. Weinberger,et al. Pentobarbital inhibits extracellular release of dopamine in the ischemic striatum , 1990, Journal of Neural Transmission / General Section JNT.
[2] R. Koehler,et al. Kappa-Opioid Receptor Selectivity for Ischemic Neuroprotection with BRL 52537 in Rats , 2003, Anesthesia and analgesia.
[3] R. Koehler,et al. Neuroprotective &kgr;-Opioid Receptor Agonist BRL 52537 Attenuates Ischemia-Evoked Nitric Oxide Production In Vivo in Rats , 2003, Stroke.
[4] H. Fields,et al. Kappa opioid receptor activation in the nucleus accumbens inhibits glutamate and GABA release through different mechanisms. , 2003, Journal of neurophysiology.
[5] R. Koehler,et al. Potent sigma 1-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine provides ischemic neuroprotection without altering dopamine accumulation in vivo in rats. , 2003, Anesthesia and analgesia.
[6] V. Chefer,et al. Modulation of the Behavioral and Neurochemical Effects of Psychostimulants by κ‐Opioid Receptor Systems , 2001, Annals of the New York Academy of Sciences.
[7] L. Terenius,et al. Modulation of neurotransmitter release in the basal ganglia of the rat brain by dynorphin peptides. , 1999, The Journal of pharmacology and experimental therapeutics.
[8] E. Mackenzie,et al. Differential time-course decreases in nonselective, mu-, delta-, and kappa-opioid receptors after focal cerebral ischemia in mice. , 1999, Stroke.
[9] I. Acworth,et al. The Measurement of Monoamine Neurotransmitters in Microdialysis Perfusates Using HPLC-ECD. , 1999, Methods in molecular medicine.
[10] A. Schoffelmeer,et al. κ1‐ and κ2‐opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum , 1997 .
[11] D. Reich,et al. Nitric Oxide Modulates Dopamine Release During Global Temporary Cerebral Ischemia , 1995, Anesthesia and analgesia.
[12] J. Clemens,et al. Ischemia increases tissue and decreases extracellular levels of acid dopamine metabolites in the rat striatum: further evidence for active transport of metabolites. , 1995, Life sciences.
[13] F. Tortella,et al. Evaluation of neuroprotection and behavioral recovery by the kappa-opioid, PD117302 following transient forebrain ischemia , 1994, Brain Research Bulletin.
[14] J. Browning,et al. Evaluation of Delayed Treatment of Focal Cerebral Ischemia With Three Selective K‐Opioid Agonists in Cats , 1994, Stroke.
[15] D. Graham,et al. Effect of the kappa-1 opioid agonist CI-977 on ischemic brain damage and cerebral blood flow after middle cerebral artery occlusion in the rat , 1993, Brain Research.
[16] D. Reich,et al. Effect of Isoflurane and Halothane on In Vivo Ischemia‐induced Dopamine Release in the Corpus Striatum of the Rat A Study Using Cerebral Microdialysis , 1993, Anesthesiology.
[17] T. Kameyama,et al. U-50,488H, a κ-opioid receptor agonist, markedly prevents memory dysfunctions induced by transient cerebral ischemia in mice , 1993, Brain Research.
[18] G. Dondio,et al. Substituted 1-(Aminomethyl)-2-(arylacetyl)-1,2,3,4- tetrahydroisoquinolines: A Novel Class of Very Potent Antinociceptive Agents with Varying Degrees of Selectivity for and μ Opioid Receptors. , 1992 .
[19] G. Dondio,et al. Substituted 1-(aminomethyl)-2-(arylacetyl)-1,2,3,4-tetrahydroisoquinolines: a novel class of very potent antinociceptive agents with varying degrees of selectivity for kappa and mu opioid receptors. , 1992, Journal of medicinal chemistry.
[20] C. Chavkin,et al. Kappa-opioids decrease excitatory transmission in the dentate gyrus of the guinea pig hippocampus , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[21] D. Scopes,et al. Neuroprotective actions of GR89696, a highly potent and selective kappa-opioid receptor agonist. , 1991, British journal of pharmacology.
[22] A. Giordani,et al. (2S)-1-(arylacetyl)-2-(aminomethyl)piperidine derivatives: novel, highly selective kappa opioid analgesics. , 1991, Journal of medicinal chemistry.
[23] R. Busto,et al. Intra-ischemic extracellular release of dopamine and glutamate is associated with striatal vulnerability to ischemia , 1988, Neuroscience Letters.
[24] R. Busto,et al. Substantia nigra lesion protects against ischemic damage in the striatum , 1987, Neuroscience Letters.
[25] J. Weinberger,et al. Nerve terminal damage in cerebral ischemia: protective effect of alpha-methyl-para-tyrosine. , 1985, Stroke.
[26] J. Weinberger,et al. Nerve terminal damage in cerebral ischemia: greater susceptibility of catecholamine nerve terminals relative to serotonin nerve terminals. , 1983, Stroke.